Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR’s internal database
1.3.2 Primary research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Lung Cancer Screening Software Market Snapshot
Chapter 3 Lung Cancer Screening Software Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Reimbursement Framework
3.4 Regulatory Framework
3.5 Market Driver Analysis
3.6. Market Restraint Analysis
3.7 Industry Challenges
3.8 Lung Cancer Screening Software Market Analysis Tools
3.8.1 Industry analysis - Porter’s
3.8.1.1 Bargaining power of suppliers - low
3.8.1.2 Bargaining power of the buyers - high
3.8.1.3 Threat of substitution - low
3.8.1.4 Threats of new entrants - moderately low
3.8.1.5 Competitive rivalry - high
3.8.2 PESTEL analysis
3.8.2.1 Political and legal landscape
3.8.2.2 Economic and social landscape
3.8.2.3 Technology landscape
3.9 Major Deals & Strategic Alliances Analysis
3.10. Market Entry Strategies
Chapter 4 Lung Cancer Screening Software Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3 Vendor Landscape
4.3.1 List of key end-users
4.3.2 Company Market Position Analysis(Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
4.3.3 Company market share analysis
4.3.4 Market differentiators
Chapter 5 Lung Cancer Screening Software Market: Regional Estimates & Trend Analysis,
5.1 Lung Cancer Screening Software Market: Regional Movement Analysis
5.2 SWOT Analysis, by Factor (Political, Legal, Economic and Technological)
5.2.1 North America
5.2.2 Europe
5.2.3 Asia Pacific
5.2.4 Latin America
5.2.5 MEA
5.3 North America
5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.3.2 U.S.
5.3.2.1 U.S. lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.3.3 Canada
5.3.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4 Europe
5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.2 U.K.
5.4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.3 Germany
5.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.4 Italy
5.4.4.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.5 France
5.4.5.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.6 Spain
5.4.6.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.7 Russia
5.4.7.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.5 Asia Pacific
5.5.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.5.2 Japan
5.5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.5.3 China
5.5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.5.4 Australia
5.5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.6 Latin America
5.6.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.6.2 Brazil
5.6.2.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.6.3 Mexico
5.6.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.7 MEA
5.7.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.7.2 South Africa
5.7.2.1市场估计和预测,2014 - 2025 (USD Thousand)
Chapter 6 Competitive Landscape
6.1 Nuance Communications, Inc.
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives
6.2 Eon
6.2.1 Company overview
6.2.2金融performance
6.2.3 Product benchmarking
6.2.4 Strategic initiatives
6.3 Koninklijke Philips N.V.
6.3.1 Company overview
6.3.2 Financial performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 Siemens Healthineers AG
6.4.1 Company overview
6.4.2 Financial performance
6.4.3 Product benchmarking
6.4.4 Strategic initiatives
6.5 PenRad Technologies, Inc.
6.5.1 Company overview
6.5.2 Financial performance
6.5.3 Product benchmarking
6.5.4 Strategic initiatives
6.6 MRS Systems, Inc.
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
6.6.4战略举措
6.7 Magview
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives
List of Tables
Table 1. Global major lung cancer screening trials and demonstration projects
Table 2. Major guidelines related to lung cancer screening
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Lung cancer screening software market summary
Fig. 5 Regional market place: Key takeaways
Fig. 6 Lung cancer screening software market: Regional movement analysis (USD Thousand)
Fig. 7 Global lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 8 North America lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 9 U.S. lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 10 Number of lung cancer screening strategies in Canada
Fig. 11 Canada lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 12. Europe lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 13 U.K. lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 14 Germany lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 15 Italy lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 16 France lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 17 Spain lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 18 Russia lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 19 Asia Pacific lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 20 Japan lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 21 China lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 22 Australia lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 23 Latin America lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 24 Brazil lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 25 Mexico lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 26 MEA lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 27 South Africa lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
Fig. 28 Market share of major lung cancer screening software players